---  
layout: startup_page  
title: "Neurenati Therapeutics"  
id: "neurenati.com"  
permalink: "/neurenatitherapeuticsneurenati.com03042025/"  
website: "http://www.neurenati.com"  
funding_round: "Seed+"  
funding_amount: "$1.7M"  
investors: "Genson Capital, Invest Quebec, (mandated by the Government of Quebec), Angels"  
about: "Neurenati Therapeutics is a Québec-based biotech company focused on developing innovative therapies for rare diseases, specifically Hirschsprung disease (HD). They are advancing a first-in-class combination therapy utilizing a growth factor, aiming to eliminate the need for surgery and minimize complications in newborns with HD. Their lead program, NEU-001, is designed to regenerate the enteric nervous system, potentially becoming a curative treatment."  
markets: "Biotech, Therapeutics, Rare Diseases"  
hq: "Québec, Canada"  
founded_year: "2020"  
linkedin: "https://www.linkedin.com/company/neurenati"  
twitter: "https://twitter.com/neurenati"  
instagram: ""  
facebook: ""  
crunchbase: "https://www.crunchbase.com/organization/neurenati-therapeutics"  
pitchbook: ""  

date_display: "04-Mar-2025"  
date: "2025-03-04"

# SEO Optimization  
meta_title: "Neurenati Therapeutics - Seed+ Funding ($1.7M)"  
meta_description: "Neurenati Therapeutics, Neurenati Therapeutics is a Québec-based biotech company focused on developing innovative therapies for rare diseases, specifically Hirschsprung disea..."  
meta_keywords: "Neurenati Therapeutics, Biotech, Therapeutics, Rare Diseases, Seed+ funding"  
canonical_url: "https://startup.projectstartups.com/neurenatitherapeuticsneurenati.com03042025/"  
---